معرفی
Fernando Camargo, Ph.D., is a Professor of Stem Cell and Regenerative Biology at Harvard University and a Principal Faculty member of the Harvard Stem Cell Institute. His lab is based at Children’s Hospital Boston, where he investigates fundamental mechanisms of adult stem cell biology, organ size regulation, and cancer pathogenesis.
- Education: Ph.D., Baylor College of Medicine (2004)
- Prior Positions: Whitehead Fellow, Whitehead Institute for Biomedical Research (2004-2009)
Research Interests include:
- YAP/TAZ signaling in organ growth and regeneration
- Single-cell lineage tracing to map hematopoietic and intestinal stem cell dynamics
- Epigenetic barriers to cellular reprogramming
- Mechanotransduction in intestinal stem cells
- Crosstalk between Hippo and metabolic pathways (e.g., glutamine/nucleotide synthesis)
- Stem cell aging and tumor suppression via transcriptional regulators
Recent Articles reveal expertise in:
- 2025: Epigenetic regulation in liver reprogramming
- 2023: Multimodal single-cell profiling and mechanotransduction in gut stem cells
- 2022: Aging-dependent transcriptional control in hematopoiesis
- 2020: In vivo stem cell imaging and Hippo-metabolism integration
- 2018: Hippo pathway genomic analysis in cancer
Scientific Awards:
- 2009 V Foundation Scholar
- NIH Director’s New Innovator Award
Lab Members include researchers developing innovative technologies for live-cell imaging and CRISPR-based lineage tracing, with clinical translation efforts in bone marrow transplantation and liver disease therapies.
۰مقاله منتشرشده
